[
    [
        {
            "time": "",
            "original_text": "医药生物行业2021年1月投资策略：紧握创新龙头 重视“春季躁动”",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "创新龙头",
                    "春季躁动"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业2021年1月投资策略：紧握创新龙头 重视“春季躁动”",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "长春高新(000661)深度报告：生长激素龙头 鼻喷疫苗新秀 未来成长性可期",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "鼻喷疫苗",
                    "成长性"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新(000661)深度报告：生长激素龙头 鼻喷疫苗新秀 未来成长性可期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "长春高新现30笔折价大宗交易 机构买入12.55亿元",
            "features": {
                "keywords": [
                    "长春高新",
                    "大宗交易",
                    "机构买入"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新现30笔折价大宗交易 机构买入12.55亿元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]